Stock DNA
Healthcare Services
INR 16,704 Cr ()
116.00
60
0.00%
0.00
0.00%
15.02
Total Returns (Price + Dividend) 
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
01-Oct-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for India Business Excellence Fund III
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
01-Oct-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for India Business Excellence Fund III
Closure of Trading Window
28-Sep-2026 | Source : BSEIntimation of Closure of Trading Window for the Quarter ended September 302026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Aug 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Exxora Trading Llp (37.05%)
Business Excellence Trust Iii - India Business Exc (11.52%)
Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is -8.96% vs 360.25% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is -13.79% vs 589.86% in Mar 2026
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 35.23% vs 28.42% in Mar 2025
YoY Growth in year ended Mar 2026 is 3.44% vs 25.84% in Mar 2025